Next-Gen Aquaculture in India: Harnessing RAS and Bio-floc Technology in Blue Economy (See 'Corp Brief') Fighting Air Pollution is continuous Programme: EFCC Secretary (See 'Corp Brief') From Struggles to Success: KVIC is Inspiring Entrepreneurial Journeys (See 'Corp Brief') NI Act is not primarily punitive rather is compensatory in nature, with focus on recovery of amount in question: HC (See 'Legal Desk') India should target 10 Million Medical Value Tourists Annually: Goyal (See 'Corp Brief') CIL's daily Average Production Rises 35% (See 'Corp Brief') e-FAST India launches PACT to support accelerated zero-emission freight deployment in India (See 'Corp Brief') Chouhan reviews action plan for strengthening KVKs through greater State participation (See 'Corp Brief') CPC - leave granted u/s Clause XII of the Letters Patent confers jurisdiction exclusively on High Court & does not bind or preserve the territorial jurisdiction of a subordinate civil court upon transfer: HC (See 'Legal Desk') Minister says early industry participation can make technologies market-ready (See 'Corp Brief') Dynamic Local Level Planning imperative for documenting Local Biodiversity: Yadav (See 'Corp Brief') National Zoological Park Organises Sunday Bird, Butterfly and Dragonfly Walks to Promote Science (See 'Corp Brief') SEBI - Writ court's intervention is required in a private contractual dispute between petitioner & broker where any contractual or statutory remedies available under SEBI Act is not invoked: HC (See 'Legal Desk') 1st Batch of Corporate Mitra Course Commences with 2879 Learners registered (See 'Corp Brief') SAIL posts strong sales and production growth in August 2026 (See 'Corp Brief') MoS felicitates 'Team India School Children' for Historic Best-Ever Performance (See 'Corp Brief') Coal India Output and Dispatch Set to Accelerate as Monsoon Effect Wanes (See 'Corp Brief') SEBI - Any notice or assessment order is invalid where passed in respect of an entity that has been struck off Register of Companies & has since been dissolved: SEBI (See 'Legal Desk') MoS launches BIO-NIVESH to Catalyse Investment and Scale-Up of Biotechnology Innovations (See 'Corp Brief') Media Registration Open for SEMICON India 2026 (See 'Corp Brief') CPC - Objection regarding pecuniary jurisdiction cannot be entertained at stage of final arguments when no such objection is raised by defendant at earliest opportunity or before settlement of issues: HC (See 'Legal Desk') Nadda inaugurates Centre for Advanced Bladder Diagnostics (See 'Corp Brief') NIELIT and Intel India launch Agentic AI Skilling Programs (See 'Corp Brief') IBC - IRP has contravened statutory mandate of IBC by omitting to maintain formal minutes of meetings & relying instead on informal email communications & where IRP omits to act strictly as per prior instructions of CoC: IBBI (See 'Legal Desk') BRICS Members reaffirm Commitment for Multilateral Cooperation in Intellectual Property (See 'Corp Brief') Digital India BHASHINI and Kathmandu Univ explore Collaboration in Language AI (See 'Corp Brief') IBCA, ADB sign MoU strengthening collaboration in Landscape Conservation (See 'Corp Brief') IPR - For deciding territorial jurisdiction at inception of suit, if plaintiff's pleadings sufficiently allege that defendant has digital presence accessible, suit cannot be summarily thrown out for lack of jurisdiction: HC (See 'Legal Desk') EPFO seeks applications from potential beneficiaries (See 'Corp Brief') CCI okays acquisition of up to 100% equity of Apollo Fertility & Apollo Specialty by Kids Clinic India (See 'Corp Brief') IBC - Definition of 'associate' u/s 79(2)(g) cannot be expanded beyond its statutory text, and procedural irregularities such as absence of forensic audit do not warrant rejection if no actual prejudice is demonstrated: NCLT (See 'Legal Desk') Wow! 7.8% growth but it also does not reveal many things! (See CORP EINSICHT)

Print

CCI olays 20% equity buy of Piramal Pharma by Clover Investments

Published: Sep 12, 2020

By TIOLCORPLAWS News Service

NEW DELHI, SEPT 12, 2020: The Competition Commission of India (CCI) approves proposed combination involving acquisition of 20% of the issued and paid-up equity share capital of Piramal Pharma Limited (Pharma Co.) by CA Clover Intermediate II Investments (Curie).

The proposed combination relates to (i) the transfer of global pharmaceutical business ( Transferred Business ) by Piramal Enterprises Limited ( PEL ) to a wholly owned subsidiary of PEL, i.e. Pharma Co., followed by, (ii) the acquisition of 20% of the issued and paid-up equity share capital of Pharma Co. by Curie ( Proposed Combination ).

Curie is a special purpose acquisition vehicle, owned and controlled by investment funds advised by the affiliates of the Carlyle Group Inc. (“ Carlyle Group ”).

The Carlyle Group is a global alternative asset manager, which manages funds that invest globally across four investment disciplines: (i) Corporate Private Equity (buyout and growth capital), (ii) Real Assets (real estate, infrastructure and energy and renewable resources), (iii) Global Credit (leveraged loans and structured credit, opportunistic credit, energy credit, private credit and distressed credit), and (iv) Solutions (private equity fund of funds program and related co-investment and secondary activities).

Pharma Co. is a wholly owned entity of PEL that will hold PEL's Transferred Business as part of the Proposed Combination, and acquire the pharmaceutical business of PEL comprising the Contract Development and Manufacturing Organisation ( CDMO ), Complex Hospital Generics ( CHG ), and Consumer Healthcare Division ( CHD )segments, as well as equity interest in certain PEL entities.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.